Demyelinating diseases, such as multiple sclerosis, are known to result from acute or chronic injury to the myelin sheath and inadequate remyelination. Its underlying molecular mechanisms, however, remain unclear. The transcription factor prospero homeobox 1 (Prox1) plays an essential role during embryonic development of the central nervous system and cell differentiation. Thus, we aimed to investigate the role of Prox1 in the survival and differentiation of oligodendrocytes. Cell viability was measured by MTT assay. Flow cytometry was conducted to analyze cell apoptosis. Ectopic-Prox1 and shProx1 were used for the overexpression and knockdown respectively of Prox1 in FBD-102b cells. Real-time reverse transcriptase polymerase chain reaction and western blot analysis were used to assess the alterations of signaling pathway-related mRNAs and proteins, respectively. Results showed that Prox1 was upregulated in differentiating oligodendrocytes, and Prox1 knockdown inhibited the differentiation of oligodendrocytes. In addition, overexpression of Prox1 promoted oligodendrocyte differentiation, as shown by the change in myelin basic protein expression. The overexpression of Prox1 had no effect on oligodendrocyte survival, while Prox1 knockdown impaired cell survival. Further study demonstrated that Prox1 knockdown promoted oligodendrocyte apoptosis and activated NOXA, a pro-apoptotic member of the Bcl-2 protein family. Knockdown of NOXA by siRNA abrogated Prox1 knockdown-induced apoptosis. Our findings indicated that Prox1 regulated the differentiation of oligodendrocyte precursor cells via the regulation of NOXA. Therefore, Prox1 could be a potential modulator of demyelinating diseases in clinical settings.
Introduction
The myelin sheath, which is derived from oligodendrocytes, is necessary for the normal function of the central nervous system (CNS). Myelination increases the speed of impulse propagation along the nerve fibers [1] , whereas demyelination impairs the integrity of myelin sheaths, thus, compromising saltatory conduction [2] [3] [4] . Remyelination is necessary for the recovery of proper nerve conduction after myelin injury. It relies on the recruitment and proliferation of oligodendrocyte precursor cells (OPCs) and their maturation into myelin-producing oligodendrocytes [5, 6] . Intracellular and extracellular factors highly regulate the maturation of oligodendrocytes. In demyelinating diseases, such as multiple sclerosis (MS), remyelination is interrupted because OPCs fail to mature, which in turn contributes to axonal degeneration and irreversible neurological disabilities [7] . Targeting the immune system through immunomodulation results in limited induction of myelin repair in patients with MS and has little effect on myelin repair and disease progression [8] . This highlights the need for alternative therapeutic interventions to enhance remyelination. Although several pathways for developmental regulation of myelination have been reported [4] , strategies to enhance remyelination remain to be developed.
Prospero homeobox 1 (Prox1) is a homeobox transcription regulator which is transiently expressed during embryonic development in the liver, pancreas, heart, and CNS, and plays a role in cell differentiation [9] [10] [11] . In the developing mammalian CNS, Prox1 is expressed in sites of gliogenesis and neurogenesis and seems to regulate the cell cycle [12] . It was recently reported that in mice, Prox1 regulated the postnatal specification of caudal ganglionic eminence-derived GABAergic interneurons [13] . Proteins in the Bcl-2 family are involved in mitochondria-mediated apoptosis [14] . BH3-only family members are proximal signaling molecules that respond to alternative and overlapping signals, and consist of at least 10 members [15, 16] . Some BH3-only family members, e.g. NOXA and Bim, can induce apoptosis via the activation of Bax/Bak after they neutralize all five known antiapoptotic Bcl-2 family members and promote caspase activation and mitochondrial dysfunction [17, 18] . The role of Prox1 in the survival and differentiation of oligodendrocytes, however, remains unclear.
In the current study, we aimed to elucidate the role of Prox1 in the survival and differentiation of oligodendrocytes. We further investigated the correlation between Prox1 and NOXA.
Materials and Methods

Cell culture and differentiation
The purification of mouse primary OPCs from the brain tissue of C57/BL6 mice (Experimental Animal Holding Facility of Zhengzhou University, Zhengzhou, China) was performed via the shaking method as previously described [19, 20] . With a slight modification of a previous protocol [21] , the isolated primary OPCs were cultured at a density of 20,000 cells per round coverslip (coated with poly-ornithine; Sigma, St Louis, USA) in NBM OPC medium (Life Technologies, Carlsbad, USA) which was supplemented with 4 mM L-glutamine (Sigma), 15 ng/ml B27 (Life Technologies), 10 ng/ml PDGF-AA (Peprotech, Rocky Hill, USA), and 1 mM sodium pyruvate (Sigma). For the differentiation, the isolated primary OPCs were cultured with NBM plus 30 ng/ml T3 (Sigma) containing 4 mM L-glutamine, 15 ng/ml B27, 10 ng/ml CNTF (Peprotech), and 15 nM sodium pyruvate (Sigma). Mouse oligodendrocyte precursor FBD-102b cells were originally established from cerebral cortical regions of p53 −/− embryos at E13 and were kindly provided by Dr Zhiqiang Gao (Nanjing Medical University). Differentiation of FBD-102b cells was guaranteed by culturing cells in medium containing 0.5% FCS at particular time.
Construction of lentiviruses and cell infection
The lentivirus encoding small hairpin RNA was prepared for Prox1 (pWP-Prox1) (GenePharma, New York, USA). The shRNA Prox1 sequence is: 5′-GGAGAAGUAUGCGCGUCA-3′; and the shRNA control sequence is: 5′-UAAGGCUAUGAAGAGAUAC-3′. 
Gene
Primer sequence
5′-AGACAGCACTGTGTTGGCTA-3′ Figure 1 . Prospero homeobox 1 (Prox1) is upregulated in differentiating oligodendrocytes FBD-102b cells were cultured with medium containing 0.5% serum for indicated time to induce differentiation. The protein (A) and mRNA (B) levels of Prox1 were examined by western blot analysis and real-time reverse transcriptase polymerase chain reaction (RT-PCR) and western blot analysis in FBD-102b cells. Primary oligodendrocyte precursor cells (OPCs) were treated with 40 ng/ml T3 for indicated time to induce differentiation. The protein (C) and mRNA (D) levels of Prox1 were measured using western blot analysis and RT-PCR in primary OPCs. Data were presented as the mean ± standard deviation (SD) of three independent experiments. *P < 0.05, **P < 0.01.
FBD-102b
Prox1 cDNA was cloned into pCDH-MCS-EF1-CopGFP vector (Life Technologies) resulting in pCDH-Prox1-EF1-CopGFP. The preparation of lentiviruses was accomplished through the co-transfection of pCDH-Prox1-EF1-CopGFP or pCDH-MCS-EF1-CopGFP with psPAX2 packaging vector (Life Technologies) and pMD2.G (Addgene, Cambridge, USA) into HEK293T cells. The expression of GFP was employed to analyze infection efficiency 2 days after infection, and the efficiency was determined to be >95%. Cells were collected at Day 6 after infection for subsequent assays.
Analysis of apoptosis and cell viability
Cell growth was determined using an MTT assay. In brief, 10 μl of MTT reagent (Life Technologies) was added to each well, and the absorbance was measured at 570 nm by using SmartReader™ 96 Microplate Absorbance Reader (Thomas Scientific, Swedesboro, USA). Cell apoptosis was analyzed using nuclear staining with Hoechst 33258 (Invitrogen, Carlsbad, USA) and Annexin V/propidium iodide (Invitrogen). Flow cytometry (BD Biosciences, San Jose, USA) was also employed for this analysis [22] . Annexin V/propidium iodide double positive cells were considered β-Actin The mRNA and protein level of Prox1 were measured using RT-PCR and western blot analysis, respectively, to confirm successful knockdown in primary OPCs. (E,F) Western blot analysis and RT-PCR were employed to detect the expression of MBP (E) and its mRNA (F) in primary OPCs. Data were presented as the mean ± standard deviation (SD) of three independent experiments. **P < 0.01.
to be in late apoptosis; the percentage was calculated by considering that all Annexin V positive cells were in apoptosis.
Real-time reverse transcriptase polymerase chain reaction
Isolation of total RNA from cells was achieved using a Mini RNA Isolation II Kit (Zymo Research, Orange, USA) according to the manufacturer's instructions. SuperScript II reverse transcriptase (Invitrogen) was used to produce cDNA with 1 μg of total RNA. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was performed using SYBR Green PCR Master Mix kit (Applied Biosystems, Foster City, USA) according to a previous protocol [23] .
The PCR was performed with 30 cycles of denaturation for 30 s at 95°C, annealing for 45 s at 60°C, and extension for 60 s at 72°C. The primers used were listed in Table 1 . Analysis of each gene expression was under the help of 2 −ΔΔCt method. 
β-Actin
Western blot analysis
Cells from each sample were lysed using RIPA lysis buffer (Life Technologies) and the proteins were resolved by 12% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. The gels were electroblotted on nitrocellulose membranes (0.45 μm; Bio-Rad, Hercules, USA), which were subsequently incubated with a blocking solution (0.1% Tween-20, 1× PBS, and 5% non-fat dry milk powder) at 25°C for 1 h. The membranes were then incubated with the primary antibody overnight at 4°C. Antibodies against Prox1, MBP, NOXA, and β-actin were purchased from Santa Cruz Biotech (Santa Cruz, USA). Thereafter, the membranes were washed with TBST and incubated with the corresponding horseradish peroxidaseconjugated secondary antibodies (Bio-Rad) for 1 h at room temperature. The bands were then visualized using SuperSignal West Pico chemiluminescence substrate (Pierce, Rockford, USA).
Small-interfering RNA reduction and plasmid transfection
To knockdown NOXA, 50 pM NOXA small-interfering RNA (siRNA) duplexes (5′-GUAAUUAUUGACACAUUUCUU-3′) and control scrambled siRNA (5′-AUUGUGGGUUACAGUGGUAUU-3′) (RiboBio, Guangzhou, China) were introduced into both primary OPCs and FBD-102b cells with Prox1 knockdown via Lipofectamine 2000.
Statistical analyses
Data were reported as the mean ± standard deviation (SD). Statistical analyses were performed using a one-way analysis of variance (ANOVA) or Student's t-test. Pairwise multiple comparisons were performed to test differences between groups (Tukey). Statistical analyses were conducted using Prism version 5 (GraphPad Software Inc., La Jolla, USA). Statistical significance was set at P < 0.05.
Results
Prox1 is upregulated in differentiating oligodendrocytes
To explore the function of Prox1 in oligodendrocyte differentiation, we first examined the expression of Prox1 after the differentiation of primary OPCs and FBD-102b cells was induced. Previous studies suggested that the FBD-102b cell line is a good candidate for analysis of the molecular mechanisms related to oligodendrocyte differentiation in vitro [24] . The FBD-102b cells were differentiated into mature oligodendrocytes with highly branched processes containing myelin basic protein (MBP), by culturing them in a medium with reduced serum levels [24] . During this process, the expression of Prox1 protein and its mRNA was gradually increased in FBD-102b cells from Days 2 to 4 (Fig. 1A,B) . In primary OPCs, the level of Prox1 protein started to rise from Day 2 after the induction of differentiation (Fig. 1C) . The expression of Prox1 mRNA in primary OPCs after induction also showed a similar pattern (Fig. 1D) . Together, these data indicated that Prox1 is upregulated in differentiating oligodendrocytes.
Prox1 knockdown inhibits differentiation of oligodendrocytes
The expression of MBP was considered to be the hallmark of mature oligodendrocytes [25] . To determine the role of Prox1 in the differentiation of oligodendrocytes, we first used an shRNA to knockdown endogenous Prox1 in FBD-102b cells and primary OPCs and examined the changes of MPB expression. Prox1 was dramatically downregulated by transfection with shRNA that targets Prox1 (Fig. 2A) . After 4 days of differentiation induction, both the mRNA level and protein expression level of MBP were increased in FBD-102b cells (Fig. 2B,C) . In contrast, MBP expression remained unchanged in the Prox1-silenced cells (Fig. 2B,C) . Similarly, knockdown of Prox1 also markedly decreased the expression of myelin proteins in primary OPCs (Fig. 2D-F) . The above data demonstrated that OPC differentiation was negatively regulated by Prox1.
Overexpression of Prox1 promotes the differentiation of oligodendrocytes
FBD-102b cells and primary OPCs were infected with pCDHProx1-EF1-CopGFP (Prox1 plasmids) for 4 days. RT-PCR confirmed the obvious increase in Prox1 expression following pCDH-Prox1-EF1-CopGFP infection in FBD-102b cells (Fig. 3A) .
The mRNA and protein levels of MBP were also elevated compared with those of the control group in FBD-102b cells (Fig. 3B,C) . Similar results were also found for the overexpression of Prox1 in primary OPCs (Fig. 3D-F) . Together, these data suggested that Prox1 promotes OPC differentiation.
FBD-102b Primary OPCs
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A B ** ** Figure 4 . Prospero homeobox 1 (Prox1) regulates oligodendrocyte survival FBD-102b cells (A) and primary OPCs (B) were infected with pCDH-Prox1 or control lentivirus before being cultured for 2 days. Cell viability was measured by MTT assay. FBD-102b cells (C) and primary OPCs (D) were infected with shRNA-Prox1 or control lentivirus before being cultured for 2 days. The CCK-8 assay was employed to examine cell viability. Data were presented as the mean ± standard deviation (SD) of three independent experiments. **P < 0.01.
Prox1 regulates oligodendrocyte survival
To investigate the effect of Prox1 on oligodendrocyte survival, cell viability was measured using the MTT assay. The overexpression of Prox1 in FBD-102b cells with pCDH-Prox1-EF1-CopGFP had no effect on cell viability (Fig. 4A) . Similar results were also found for primary OPCs overexpressing Prox1 (Fig. 4B) . However, the knockdown of Prox1 significantly decreased the number of viable primary OPCs and FBD-102b cells (Fig. 4C,D) . These data indicated that Prox1 regulates oligodendrocyte survival.
Prox1 knockdown promotes oligodendrocyte apoptosis
To examine whether the loss of cell viability was due to apoptotic cell death, the number of primary OPCs and FBD-102b cells stained with Hoechst 33258 (i.e. with condensed chromatin and micronucleation) were counted. The knockdown of Prox1 induced~20% or 25% fragmented nuclei positive cells after 48 h in primary OPCs and FBD-102b cells, respectively (Fig. 5A,B) . The typical apoptotic cell morphology was also observed after inhibition of Prox1 (Fig. 5C,D) . Apoptosis was also assessed using the Annexin V analysis after the Prox1 shRNA infections, and over 20% of primary OPCs and FBD-102b cells exhibited Annexin V immunoreactivity (Fig. 5E,F) . These data indicated that Prox1 knockdown promotes oligodendrocyte apoptosis.
Induction of NOXA mediates oligodendrocyte apoptosis induced by Prox1 knockdown
To determine the potential role of BH3-only proteins in Prox1 knockdown-induced apoptosis, we first examined the mRNA levels of its major members following Prox1 knockdown in both primary OPCs and FBD-102b cells using quantitative RT-PCR assay. The mRNA levels of NOXA and Bim were significantly increased, whereas PUMA and Bad remained unchanged before and after Prox1 shRNA infection (Fig. 6A,B) . Among them, the mRNA level of NOXA was increased by almost 10-fold and western blot analysis demonstrated increased NOXA protein levels ( Fig. 6A-D) . Next, we injected siRNA against NOXA to assess whether NOXA participates in Prox1 knockdown-induced apoptosis. The percentage of cells with fragmented nuclei after Prox1 knockdown was significantly abrogated in the NOXA siRNA group compared to the Scramble siRNA group (Fig. 6E,F) . These findings suggested that β-Actin Prox1 knockdown specifically induced NOXA, which was required for Prox1 knockdown-induced apoptosis in oligodendrocytes.
Discussion
MS is an autoimmune disorder that affects the CNS, and is characterized by the damage of oligodendrocytes and myelin sheaths [26] . Remyelination occurs when OPCs are recruited to the lesions and differentiated into myelinating oligodendrocytes under conditions of various axon-derived and extracellular factors [27] . Nevertheless, remyelination could be unsuccessful if differentiation of OPCs is inhibited by suppressive factors and accompanied by the absence of a beneficial cellular environment [28, 29] . Therefore, it is necessary to better understand the factors that regulate OPC differentiation to enable the elucidation of new targets that are good for remyelination. In the current study, we demonstrated that the expression level of Prox1 was upregulated in differentiating oligodendrocytes. Furthermore, Prox1 regulated the differentiation of OPCs via the regulation NOXA.
The Prox1 transcription factor, especially its homeo-prospero domain, is highly conserved among vertebrates [30, 31] . Prox1 is crucial for the development of several organs, and Prox1-deficient mice were found to die before birth due to various developmental defects [32, 33] . Previous studies have demonstrated the role of Prox1 in the development of the liver, pancreas, lymphatic vasculature, lens, and heart [9, 11, 34] . Some studies also revealed the role of Prox1 in skeletal muscle development and fiber-type specification [35] [36] [37] . In zebrafish, the U-boot (Ubo) gene, which regulates slowversus fast-fiber differentiation pathways, activates Prox1 in slow myoblasts. This is crucial for the final stage of fiber development and the appropriate organization in slow fibers [35] . Recently, Petchey et al. [37] demonstrated that Prox1 is required for repressing fast troponin T3, troponin T2, and myosin light chain 1 in both cardiac and skeletal muscle of mice, indicating the conservation of Prox1 function in vertebrates [36] . Indeed, in the present study, we demonstrated that Prox1 stimulation could significantly increase both the protein and mRNA expression levels of MBP, which are hallmarks of mature oligodendrocytes. Conversely, Prox1 knockdown decreased the expression of MBP. Furthermore, Prox1 was essential for the survival and proliferation of OPCs. These results highly support the concept that Prox1 is required for oligodendrocyte cell identity [38, 39] .
Oligodendrocytes often die in the MS lesions [40] [41] [42] . T-celland antibody-mediated injuries simultaneously destroy oligodendrocytes and myelin sheaths. Some oligodendrocytes may not be killed by the initial inflammation, but their myelin sheaths may be damaged. Repeated immune attacks, however, will cause death of the surviving oligodendrocytes. They may also die from programmed cell death due to their final differentiation, which is physiologically excluded from remyelination [43] . In the current study, we found that Prox1 knockdown promoted oligodendrocyte apoptosis. Taken together, our results provide evidence that Prox1 is required for the differentiation of OPCs through the maintenance of OPC survival. When we explored the mechanism of Prox1 knockdown-induced apoptosis in OPCs, NOXA was found to be induced among the important BH3 only pro-apoptotic proteins. NOXA works indirectly via 'sensitization' or 'de-repression', interacts only with protective Bcl-2-like members, and triggers the loss of permeabilization of the mitochondrial outer membrane as well as the release of cytochrome c, which is a component of the classical mitochondrial apoptosis [44] . Further study to demonstrate that NOXA induction was required for the apoptosis induced by genetic change. However, NOXA knockdown could not completely inhibit the apoptosis of OPCs. Other apoptosis mediators might also play a role in this mechanism, which warrants further study.
In conclusion, our study demonstrated the upregulation of Prox1 in differentiating oligodendrocyte cells. Inhibition of Prox1 impaired the differentiation of oligodendrocyte cells, while overexpression of Prox1 enhanced the differentiation, with a significant effect on the survival and apoptosis of OPCs. Additionally, Prox1 knockdown activated NOXA-mediated apoptosis. Therefore, Prox1 could be a promising modulator of demyelinating diseases in a clinical setting.
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